AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2025

Feb 19, 2025

30893_dirs_2025-02-19_64a88935-3965-4722-b1da-6b26c9da5fa4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2025-02-18

Reporting Person: Downing Steven R (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-18	Common Stock	A	51878.00	$0.00	Acquired	216701.00	Direct
2025-02-18	Common Stock	F	51878.00	$24.623	Disposed	164823.00	Direct
2025-02-18	Common Stock	F	12925.00	$24.623	Disposed	151898.00	Direct

Footnotes

F1: 51,878 shares are performance based shares where the total number of shares granted were based on long term performance incentives.

F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan

F3: This transaction was executed in multiple trades at prices ranging from $24.36 to $24.78. The price reported above reflects the weighted average price.